Inhibition of human colon cancer by intermittent opioid receptor blockade with naltrexone

Cancer Letters

Volumn 101, Issue 2, 1996, Pages 159-164

  Hytrek, Staci D ^a   McLaughlin, Patricia J ^a   Lang, C Max ^a   Zagon, Ian S ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Colon cancer; Enkephalin; Naltrexone; Opioid antagonist; Opioid receptor

Indexed keywords

METENKEPHALIN; NALTREXONE; OPIATE ANTAGONIST; OPIATE RECEPTOR; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CANCER INHIBITION; COLON CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR BLOCKING; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALIA; MUS MUSCULUS; TRITIUM;

EID: 0029986111     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(96)04119-5     Document Type: Article

References (20)

1. Boland, C.R. (1993) The biology of colorectal cancer. Cancer, 71 (Suppl.), 4180-4186.
2. Boring, C.C., Squires, T.S. and Tong, T. (1992) Cancer statistics. CA, 42, 19-38.
3. Braude, M.C. and Morrison, J.M. (1976) Preclinical toxicity studies of naltrexone. Natl. Inst. Drug Abuse Res. Monogr., 9, 16-26.
4. Gross, J.L., Herblin, B.A., Dusak, B.A., Czerniak, P., Diamond, M.D., Sun, T., Eidsvoog, K., Dexter, D.L. and Yayon A. (1993) Effects of modulation of basic fibroblast growth factor on tumor growth in vivo. J. Natl. Cancer Inst., 85, 121-131.
5. Hytrek, S.D., Lang, C.M., McLaughlin, P.J. and Zagon, I.S. (1995) Characterization of the zeta (ζ) opioid receptor in human colon cancer. FASEB J., 9 (Abstract), A703.
6. Hytrek, S.D., Lang, C.M., Smith, J.P., McLaughlin, P.J. and Zagon, I.S. (1995) Opioid growth factor modulates tumorigenesis of human colon carcinoma grown in nude mice. Gastroenterology, 108 (Abstract), A483.
7. Iishi, H., Tatsuta, M., Baba, M., Yamamoto, R. and Taniguchi H. (1992) Enhancement by bombesin of colon carcinogenesis and metastasis induced by azoxymethane in Wistar rats. Int. J. Cancer, 50, 834-839.
8. Lahm, H., Suardet, L., Laurent, P.L., Fischer, J.R., Ceyhan, A., Givel, J.C. and Odartchenko, N. (1992) Growth regulation and co-stimulation of human colorectal cancer cell lines by insulin-like growth factor I, II and transforming growth factor alpha. Br. J. Cancer, 65, 341-346.
9. McLaughlin, P.J. and Zagon, I.S. (1987) Modulation of human neuroblastoma transplanted into nude mice by endogenous opioid systems. Life Sci., 41, 1465-1472.
10. Osieka, R., Houchens, D.P. and Goldin, A. (1977) Chemotherapy of human colon cancer xenografts in athymic nude mice. Cancer, 40, 2640-2650.
11. Radulovic, S., Miller, G. and Schally, A.V. (1991) Inhibition of growth of HT-29 human colon cancer xenografts in nude mice by treatment with bombesin/gastrin releasing peptide antagonist (RC-3095). Cancer Res., 51, 6006-6009.
12. Smith, J.P. and Solomon, I.E. (1988) Effects of gastrin, proglumide, and somatostatin on growth of human colon cancer. Gastroenterology, 95, 1541-1548.
13. Zagon, I.S. and McLaughlin, P.J. (1983) Naltrexone modlates tumor response in mice with neuroblastoma. Science, 221, 671-673.
14. Zagon, I.S. and McLaughlin, P.J. (1983) Opioid antagonists inhibit the growth of metastatic murine neuroblastoma. Cancer Lett., 21, 89-94.
15. Zagon, I.S. and McLaughlin, P.J. (1984) Duration of opiate receptor blockade determines tumorigenic response in mice with neuroblastoma: a role for endogenous opioid systems in cancer. Life Sci., 35, 409-416.
16. Zagon, I.S. and McLaughlin, P.J. (1987) Endogenous opioid systems regulate cell proliferation in the developing rat brain. Brain Res., 412, 68-72.
17. Zagon, I.S. and McLaughlin, P.J. (1987) Modulation of murine neuroblastoma in nude mice by opioid antagonists. J. Natl. Cancer Inst., 78, 141-147.
18. Zagon, I.S. and McLaughlin, P.J. (1989) Opioid antagonist modulation of murine neuroblastoma: a profile of cell proliferation and opioid peptides and receptors. Brain Res., 480, 16-28.
19. Zagon, I.S. and McLaughlin, P.J. (1991) The role of endogenous opioids and opioid receptors in human and animal cancers. In: Stress and Immunity, pp. 343-356. Editors: N.P. Plotnikoff, A.J. Murgo, R.E. Faith and J. Wybran, CRC Press, Caldwell, NJ.
20. 5]-enkephalin to acute opioid antagonist (naltrexone) exposure. Mol. Brain Res., 33, 111-120.